1734.0000 44.00 (2.60%)
NSE Sep 18, 2026 15:31 PM
Volume: 1.2M
 

1734.00
2.60%
Deven Choksey
Aurobindo Pharma is well positioned to deliver sustainable double-digit growth, supported by healthy momentum across its US, Europe, India, and Growth Markets businesses, along with a steady cadence of complex product launches.
Aurobindo Pharma has gained 36.64% in the last 6 Months
More from Aurobindo Pharma Ltd.
Recommended